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During inflammation in the skin keratinocytes can express 
major histocompatibility complex class II molecules but are 
unable to present nominal antigens to resting T cells. Certain 
bacteria including staphylococci produce a new class of anti-
gens termed superantigens that are very potent T-cell activa-
tors. Using an in vitro model with cultured normal human 
keratinocytes and purified allogeneic T cells, we demon-
strated that major histocompatibility complex class 11+ kera-
tinocytes can activate T cells in the presence of the superanti-
gen staphylococcal enterotoxin B. Major histocompatibility 
complex class 11+ keratinocytes activated T cells at concen-
T he major histocompatibility complex (MHC) class II molecules are normally only present on monocytes, B cells, and dendritic cells, including Langerhans cells [1]. Classical antigen presentation of proteins by these cell types involves endocytosis followed by partial di-
gestion and binding' of the peptide fragments to MH C class II mole-
cules [2,3]. MHC class II molecules with bound pep tides are then 
expressed on the surface of the antigen-presenting cell and interact 
with the T-cell receptor in conjunction with CD4 on the T cells. If 
the specificity of the interacting T cell fits the particular antigen 
being presented, the T cell is activated. 
During inflammation, MHC class II molecules can also be ex-
pressed aberrantly on other cell types, including keratinocytes [4-
6]. In contrast to the well described function of MHC class II mole-
cules on dendritic antigen-presenting cells, the function of 
aberrantly expressed MHC class II molecules has been controver-
sial. When aberrantly expressed MHC class II molecules or chemi-
cally modified splenic cells presented antigenic peptides to T-cell 
clones, the result was not proliferation but instead antigen-specific 
long-lasting unresponsiveness [7 -11]. Therefore, aberrantly ex-
pressed MHC class II molecules have been proposed to constitute a 
down-regulatory pathway of the immune system. 
Superantigens [12] are proteins that can activate families ofT cells 
bearing specific T-cell receptor fi-chains [13] . Superantigens are 
extremely potent and can activate T cells at concentrations less than 
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trations of staphylococcal enterotoxin B as low as 100 pg/ ml. 
The activation required contact between keratinocytes and T 
cells, was inhibited with a monoclonal antibody to human 
leukocyte antigen DR, -DQ, and was not affected by fixation 
of the keratinocytes. These data show that major histocom-
patibility complex class 11+ keratinocytes activate T cells in 
the presence of the superantigen staphylococcal enterotoxin 
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10 fg/ml [14]. T-cell activation by superantigens is dependent upon 
antigen-presenting cells that express MHC class II molecules [15]. 
Superantigens induce activation by cross-linking MHC class II mol-
ecules on an antigen-presenting cell and the T-cell receptor [16]. 
However, processing of the superantigen is not required, because 
formalin-fixed antigen-presenting cells and fibroblasts transfected 
with human leukocyte antigen (HLA) -DR, -DQ, and -DP ate 
capable of presenting superantigen to T cells [14,17 - 18]. Given 
these observations, one would predict that aberrantly expressed 
MHC class II molecules also may be able to present superantigen to 
T cells. 
In this paper we demonstrate that aberrantly expressed MHC 
class II molecules on keratinocytes indeed have the capacity to 
present superantigen to allogeneic T cells, resulting in T-cell prolif-
eration. 
MATERIALS AND METHODS 
Isolation of T Cells Human peripheral blood mononuclear cells 
(PBMCs) were isolated from heparinized venous blood by density gradient 
centrifugation on Ficoll-Hypaque (Phannacia, Uppsala, Sweden). Mononu_ 
clear cells at the interface were divided into adherent monocytes and non-
adherent PBMCs by adherence to plastic. The monocyte depleted PBMC:s 
were reacted with murine IgG antibody to human HLA-DR (DAKO, Co-
penhagen, DK). The PBMCs were then mixed with immunomagnetic 
beads coated with antibody to mouse igG (Dynal, Oslo, Norway) for 30 min 
in a rotating rack at 4 ° C. Cells bound to the beads were removed using a 
magnet for 6 min, and the cells left in suspension were used as purified 
allogeneic HLA-DR- T cells. 
Cultivation of Keratinocytes Normal human keratinocytes were cul-
tured in keratinocyte growth medium (KGM) (Clonetics, San Diego, Cf\) 
using standard methods that eliminate cell types other than keratinocytes, 
including COl + cells [19]. Keratomes of human epidermis were incubated 
with 0.25.% (w Iv) trypsi.n (~IBCO, Paisley, Scotland) and 0.1 % (w Iv) 
ethylenedlamme tetraacetlc aCId (EDTA, Merck, Darmstadt, FRG) in phos-
phate-buffered saline (PBS) for 30 min at 37 °C. The tissue was gently 
shaken to separate the cells. Cell aggregates were dissociated by pipettillg 
and the trypsin neutralized with 10% fetal calf serum (FCS) in PBS. The 
cells were spun at 250 X g, resuspended in KGM, and seeded in tissue_ 
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culture-treated petri dishes. Upon confluence, keratinocytes were detached 
in 0.025% (w Iv) trypsin and 0.01 % (w Iv) EDT A in PBS and seeded in new 
petri dishes. Keratinocytes were used for assay after three to five passages. 
MHC class II molecules were induced on keratinocytes by interferon 
(IFN)-g (Genzyme, Cambridge, MA) used at a final concentration of 1000 
u/ml for 48 - 72 h [6]. Immunostaining of the keratinocytes revealed more 
than 75% HLA-DR+ and intercellular adhesion molecule (ICAM)-l + kera-
tinocytes. 
ICAM-l induction without simultaneous MHC class II induction was 
obtained by incubating the keratinocytes with 10 ng/ml tumor necrosis 
factor (TNF)-a (Genzyme) for 48 h [20]. Immunostaining of these kerati-
nocytes revealed more than 75% ICAM-l+ but HLA-DR- keratinocytes. 
Activation Assay Ten thousand keratinocytes were seeded in flat-bottom 
microtiter plates in KGM. After 1-d, 1000 u/ml IFN-g was added to induce 
MHC class II. After 2 or 3 d, the micro titer plates with the keratinocytes 
were gamma-irradiated (3600 rad). The cells were washed three times in 
PBS. In the experiments using fixed keratinocytes, the keratinocytes were 
incubated with 1 % (w Iv) paraformaldehyde for 15 min at room temperature 
before four washes in PBS, 4 h incubation, and three additional washes in 
PBS to remove residual paraformaldehyde and cytokines. Fifty thousand 
allogeneic T cells, staphylococcal enterotoxin B (SEB) (SIGMA) at varying 
concentrations, and 6000 ng/ml purified protein derivative (PPD) (Seru-
minstituttet, Copenhagen, Denmark) were added in a medium consisting of 
60% KGM without hydrocortisone and 40% AIM V (GIBCO) to a final 
volume of 200,u1. The cells were incubated in a 100% humidified atmo-
sphere containing 5% CO2 at 37'C. After 3 d, 1.0 ,uCi (methyPH)-Thy-
midine (TdR) (Amersham, Amersham, UK), specific activity 25 Ci/mmol, 
was added to each well . After 18 h, 25 ,u12.5% trypsin was added to each well 
and the microtiter plate incubated at 37'C for 1 h. The cells were harvested 
onto filter paper using a cell harvester (Skatron, Tranby, Norway), and 
activity incorporated in the cells was assessed by liquid scintillation. In some 
experiments, keratinocytes were separated from the T cells. Fifty thousand 
keratinocytes were seeded in each well in 24-well plates in KGM. Mter 1 d, 
IFN-g was added to induce MHC class II molecules. After 3 d, the cells were 
washed twice and the above-described medium with varying concentrations 
of SEB added. The Transwell (Costar, Cambridge, MA) O.4-,um pore mem-
brane was then placed on the top of the wells and 2 X 105 purified allogeneic 
T cells was added to the upper compartment. The lower compartment 
volume was 500 ,ul and the upper volume was 100 ,ul, up to a final volume of 
600 ,ul. After 3 d, 1.0 ,uCi TdR was added to each well, and after 18 h, 50 ,ul 
of the cell suspension from the upper compartment was harvested onto filter 
paper and the activity incorporated in the cells was assessed by liquid scintil-
lation. 
Monoclonal Antibodies Used for Inhibition Studies and ELISA 
Kit Murine antibody towards human ICAM-l (RR1/1.1.1; IgG, ) was 
kindly provided by R. Rothlein. Murine hybridomas secreting anti-HLA-
DR, -DQ (9.3F10; IgG2a) [21], anti-thrombospondin (ahTSP-1; IgGu.) 
[22], anti-HLA-A, -B, -C (BB7.7; IgG2b ) [22], and anti - IFN-g (y3-11.1; 
IgG,) [22] antibodies were purchased from the American Type Culture 
Collection (Rockville, MD). Supernatants were affinity purified on aT-gel 
[23] synthesized from divinyl sulfone-activated agarose beads (Mini-Leak 
High, Kem-En-Tec, Copenhagen, Denmark) using 0.75 M (NH.),SO. for 
adsorbtion. The eluates were desalted on a Sephadex G25 (Pharmacia, Upp-
sala, Sweden) column. The approximate protein concentrations were deter-
mined using the Bradford dye binding assay [24] using dilutions of bovine 
serum albumin (SIGMA) as a standard. Relative purity of the antibodies was 
verified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE). Before being added to the assay, the protein concentrations of 
purified IgGs were matched. 
IFN-g concentrations were determined using a commercial enzyme-
linked immunosorbent assay (ELISA) kit (Endogen, Boston, MA). 
RESULTS 
IFN-g-Activated Keratinocytes Can Present Superantigen 
to Allogeneic T Cells, Resulting in T-Cell Activation 
When the superantigen SEB was added to MHC class II+ keratino-
cytes and T cells, the result was vigorous proliferation. This is 
shown in Fig 1, where counts per minute of background levels of 
keratinocytes alone, keratinocytes in the presence ofSEB, and kera-
tinocytes and T cells alo·ne (Fig 1, columns, 1-4) were far below the 
substantial proliferation ofT cells and keratinocytes in the presence 
of SEE (Fig 1, column 6, solid bar), n = 12. The proliferation can be 
uniquely attributed to the T cells because the keratinocytes prior to 
the addition of T cells had received 3600 rad gamma-irradiation. 
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Similar results were obtained with another superantigen staphylo-
coccal enterotoxin A. As expected due to both MHC restriction and 
the limitations with the keratinocytes as accessory cells, incubation 
of nominal antigen with MHC class II+ keratinocytes and T cells 
did not result in proliferation of T cells sensitized to the antigen. 
This is also shown in Fig 1, where counts per minute ofT cells and 
keratinocytes in the presence ofPPD (Fig 1, KC+T+PPD, column 
5) did not exceed background levels ofkeratinocytes and T cells (Fig 
1, KC+T, column 4), either with control keratinocytes (Fig 1, 
hatched bars) or when the keratinocytes were pretreated with IFN-g 
and therefore were MHC class II+ (fig 1, closed bars). 
Interestingly, control keratinocytes, i.e., keratinocytes not pre-
treated with IFN-g, also stimulated T cells when SEB was added, 
although to a far lesser extent (Fig 1, column 6, hatched bar). This may 
be secondary to low-level IFN-g release from the T cells and subse-
quent MHC class II induction on the keratinocytes. The initially 
MHC class n- control keratinocytes would therefore become MHC 
class II+ during the assay and be able to present SEB to the T cells. 
The time-response curve of T-cell stimulation by keratinocytes in 
the presence of SEB (Fig 2) supports this hypothesis. The T-cell 
stimulation by IFN-g-pretreated keratinocytes in the presence of 
SEB reached maximum as early as day 3 (Fig 2, solid line). The T-cell 
stimulation by control keratinocytes in the presence ofSEB reached 
the same level but delayed at least 2 d to day 5 (Fig 2, dashed line). 
The time difference demonstrates that the T -cell stimulation is 
secondary to other events in the control keratinocytes. Further-
more, we immunostained the control keratinocytes for HLA-DR 
expression before and after incubation for 3 d with T cells and SEB 
or SEB alone. When initially HLA-DR- control keratinocytes were 
incubated for 3 d with T cells and 1000 ng/ml SEB, more than 25% 
of the keratinocytes became HLA-DR+ and thus able to present 
SEB. In contrast, keratinocytes incubated with SEB alone remained 
HLA-DR-. Despite lack of TdR incorporation (counts per 
minute < 100), we found IFN-g (12 ± 1-41 ± 1 pg/ml) in super-
natants from T cells alone incubated for 72 h either without stimu-
lus or with 500 ng/ml SEB. Furthermore, 10 ,ug/ml of monoclonal 
antibody to IFN-g inhibited T-cell activation by control keratino-
cytes in the presence of 1 ,ug/ml SEB with 30% ± 2 inhibition 
(mean ± standard deviation of three separate experiments) relative 
to the control antibody anti - HLA-A, -B, -c. Finally, fixation of 
the keratinocytes prior to the addition ofT cells and SEB abrogated 
the ability of control keratinocytes to activate T cells (Fig 3, dotted 
barvs hatched bar) whereas it did not affect T-cell activation by MHC 
class n+ IFN-g-pretreated keratinocytes in the presence of SEB 
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Figure 1. Keratinocytes stimulate allogeneic T cells in the presence ofSEB. 
Fifty thousand purified PPD-sensitized T cells (T) and/or SEB 5000 ng/ml 
(SEB) and/or PPD 6000 ng/ml (PPD) were added to gamma-irradiated 
either control keratinocytes (KC-, hatched bars) or keratinocytes pretreated 
with IFN-g (KC+, solid bars). After 3 d, the cells were pulsed overnight with 
TdR and radioactivity incorporated in the cells assessed. Bars, mean ± 
standard deviation of counts per minute obtained from triplicate determina-
tions. IFN-g- treated keratinocytes induced brisk proliferation ofT cells in 
the presence of the superantigen SEB (co/14ll1l1 6, solid bar). 
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Figure 2. Time-response curve of keratinocyte activation of T cells in the 
presence ofSEB. Fifty thousand purified T cells and 5000 ng/ml SEB were 
added to gamma-irradiated either control keratinocytes (daslled line) or kera-
tinocytes pretreated with IFN-g (solid line). At different time points (ab-
scissa) the cells were pulsed overnight with TdR. The mean ± standard 
deviation counts per minute of triplicate determinations is expressed on the 
ordinate. The T-cell stimulation by control keratinocytes is delayed com-
pared to IFN-g - pretreated keratinocytes. 
(Fig 3, open bar vs solid bar) . Therefore, the observation that control 
keratinocytes activate T cells when SEB is present in this assay 
system does not conflict with the notion that the superantigens 
require MHC class II molecules to stimulate T cells [15]. 
Keratinocytes Stimulate T Cells in the Presence of SEB at 
Concentrations a~ Low as 0.1 ngj ml The dose response for 
the keratinocyte and SEB activation of T cells is shown in Fig 4. 
IFN -g - treated keratinocytes stimulated T cells in the presence of 
SEB at concentrations as low as 0 .1 ngjml (Fig 4, solid line). Again, 
control keratinocytes also stimulated T cells although only at con-
centrations of SEB above 100 ngjml (Fig 4, dashed line). Thus con-
trol keratinocytes stimulated T cells only when the SEB concentra-
tion was 1000 times greater than the level required when the 
keratinocytes had been pretreated with IFN-g. 
Activation ofT Cells by IFN-g - Treated Keratinocytes in the 
Presence of SEB Requires Contact Between Keratinocytes 
and T Cells To determine whether contact between keratino-
cytes and T cells was required for activation, we separated the kera-
tinocytes and the T cells by a membrane with O.4-flm diameter 
pores. When T cells and keratinocytes in the presence of SEB were 
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Figure 3. Fixation ofMHC class n- keratinocytes abrogates their ability to 
activate T cells in the presence of SEB but fixation does not affect that ability 
of MH C class 11+ keratinocytes. Fifty thousand purified T cells and 500 
ng/ml SEB were added to live (solid bar) or fixed (open bar) gamma-irra-
diated keratinocytes pretreated with IFN-g and live (hatched bar) or fixed 
(dotted bar) control keratinocytes. After 3 d, the cells were pulsed overnight 
with TdR. The mean ± standard deviation counts per minute of triplicate 
determinations is expressed on the ordinate. 
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Figure 4. Dose-response curve of keratinocyte-induced activation of 'T 
cells in the presence of SEB. Fifty thousand purified T cells and varying 
concentrations of SEB (abscissa) were added to gamma-irradiated either 
control keratinocytes (dashed line) or keratinocytes pretreated with IFN_g (solid line). After 3 d, the cells were pulsed overnight with TdR. 'The 
mean ± standard deviation counts per minute of triplicate determinations is 
expressed on the ordinate. MHC class 11+ keratinocytes and SEB activates T 
cells at concentrations of SEB as low as 0.1 ng/ml. 
separated, there was almost no activation of the T cells, in contrast 
to the vigorous activation when contact between keratinocytes and 
T cells was present. This is illustrated in Fig 5 by the stimulation 
index between (keratinocytes + T cells + SEB) and (T cells + 
SEB), when the keratinocytes and T cells were separated (Fig 5, lift 
column), and when contact between keratinocytes and T cells Was 
present (Fig 5, right column). From these data we conclude that 
contact between keratinocytes and T cells is critical for IFN-g_ 
treated keratinocytes to activate T cells in the presence of SEB. 
T-Cell Activation by IFN -g - Treated Keratinocytes in the 
Presence ofSEB Can Be Inhibited by Monoclonal Antibodies 
to HLA-DR, -DQ and ICAM-l, But Not to HLA-A, -R 
-C To further elucidate the mechanism by which keratinocyte~ 
and SEB stimulated T cells, we attempted to inhibit the T-cell 
stimulatory effect of keratinocytes in the presence of SEB with a 
monoclonal antibody to HLA-DR, -DQ that previously has been 
shown to incompletely inhibit SEB activation of PBMCs [18]. As 
shown in Fig 6, the effect could be inhibited with anti-HLA-DR 
-DQ (Fig 6, solid line and Fig 7, hatched bars), whereas an isotype~ 
matched irrelevant control antibody (Fig 6, dashed line) and an anti-
body to HLA-A, -B, -C (Fig 7, open bars) had no inhibiting effect. 
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Figure 5. Stimulation indexes of keratinocytes + SEB + T cells over 
keratinocytes + T cells with and without keratinocyte and T-cell sepat';l_ 
tion. Keratinocytes and T cells were either separated (left bar) or not sepa-
rated (right bar) by a membrane with O.4-J.lm pores. Bars, stimulation 
index ± standard deviation ofIFN-g-pretreated keratinocytes + SEB + T 
cells over T cells + SEB. Separation of T cells and keratinocytes abrogated 
T-cell stimulation by keratinocytes in the presence of SEB (left bar versus 
rig/It bar) . 
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Figure 6. Monoclonal antibody to HLA-DR, -DQ inhibits keratinocyte 
activation ofT cells in the presence ofSEB. Fifty thousand purified T cells, 
100 ng/m1 SEB, and varying concentrations (abscissa) of purified monoclo-
nallgG antibody to HLA-DR, -DQ (solid litle) or irrelevantepitope (dashed 
Uti e) we~e added to gamma-irradiated keratinocytes pretreated with IFN-g. 
After 3 d, the cells were pulsed overnight with TdR. The mean ± standard 
deviation counts per minute of triplicate determinations is expressed on the 
ordinate. 
Antibody to ICAM-l also inhi~ited T-cell activation by keratino-
cytes in the presence of SEB (Fig 7, dotted bars). 
ICAM.l+, MHC Class n- Keratinocytes Do Not Activate T 
Cells in the Presence ofSEB To discriminate between the role 
ofMHC class II and ICAM-l molecules we obtained ICAM-l+ but 
MHC class II- keratinocytes by treating keratinocytes with tumor 
necrosis factor (TNF)-a for 48 h before addition ofT cells and SEB. 
Figure 8 demonstrates ~hat ICAM-l expression ~~ keratino~ytes is 
not sufficient for keratmocytes to acqUire the ablbty to activate T 
cells in the presence of SEB. The ICAM-l+ but MHC class II.-
keratinocytes (Fig 8, hat~hed b~rs) are. comparable to control ~~ratl­
nocytes (Fig 8, open bars) m therr relative (see above) lack of ability to 
stimulate T cells in the presence ofSEB. In contrast, IFN-g-treated 
keratinocytes, which are ICAM-1 + and ~HC cl~ss II+, do stimulate 
keratinocytes in the presence of SEB (Fig 8, solId bars). 
DISCUSSION 
T-cell activation by keratinocytes in the presence of SEB was inhib-
ited by a monoclonal an~ibody to HLA-DR, ~DQ (Fi~s 6 and 7) but 
neither by an irrelevant ISO type-matched antibody (Fig 6) nor by an 
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Figure 7. Monoclonal antibodies to HLA-DR, -DQ and ICAM-1 but not 
to HLA-A, -B, -C inhibit T-cell activation by keratinocytes in the presence 
of 100 ng/ml SEB. Fifty thousand purified T cells, and o (solid bar), 5, or 10 
flg/mI monoclonal antibody to HLA-A, -B, -C (opell bar), HLA-DR, -DQ 
(hatched bar) , or ICAM-l (dotted bar) and 1~0 ng/ml SEB were added to 
gamma-irradiated keratinocytes pretreated With IFN-g. After 3 d, the cells 
were pulsed overnight with TdR:. ~ctivity incorporated by triplicate deter-
mir1ations (mean ± standard deviatIOn) IS expressed on the ordmate. 
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Figure 8. ICAM-l+ but MHC class II- keratinocytes do not stimulate T 
cells in the presence of SEB. Fifty thousand purified T cells and varying 
concentrations of SEB (abscissa) were added to gamma-irradiated either 
control keratinocytes (oPell bar), keratinocytes pretreated with TNF-a 
(hatched bar), or keratinocytes pretreated with IFN-g (solid bar). After 3 d, 
the cells were pulsed overnight with TdR. The mean ± standard deviation 
counts per minute of triplicate determinations is expressed on the orditlale. 
antibody to HLA-A, -B, -C (Fig 7). Therefore T-cell activation by 
keratinocytes in the presence of SEB is MHC class II dependent, 
which is also suggested by the demonstrated high-affinity binding 
of SEB to MHC class II molecules [25] . 
An antibody to ICAM-1 also inhibited T-cell stimulation by ker-
atinocytes in the presence of SEB (Fig 7). ICAM-1 was induced on 
keratinocytes by the doses ofIFN-g used in this paper [20] . ICAM-1 
has previously been shown to be involved in T-cell activation by 
keratinocytes, even by a MHC-independent mechanism [26]. How-
ever, with regard to T-cell activation by keratinocytes in the pres-
ence of SEB, ICAM-1 expression on the keratinocytes is not suffi-
cient (Fig 8). Whether the inhibitory effect of anti-ICAM-1 on 
T-cell activation by keratinocytes in the presence of SEB is due to 
hindrance of sufficient contact between T cells and keratinocytes 
for superantigen presentation [27] or to inhibition of a regular co-
stimulatory signal through the ICAM-l ligand LFA-1 [28] is un-
known. 
It may be argued that residual monocytes in the purified T cells 
are responsible for the specific interaction ofSEB with MHC class II 
molecules and that the keratinocytes are merely secreting accessory 
cytokines. This is highly unlikely. First, separation of the keratino-
cytes from the T cells abrogated T-cell stimulation by keratinocy~es 
in the presence ofSEB (Fig 5). The O.4-J,lm pore membrane permits 
cytokines released from the keratinocytes to diffuse to the T cells, 
but nevertheless T-cell activation were abrogated (Fig 5). Second, 
paraformaldehyde-fixed IFN -g - pretreated keratinocytes, which 
are incapable of producing cytokines, stimulated T cells in the pres-
ence of SEB as much as live keratinocytes (Fig 3) . 
T cells were also activated by control keratinocytes in the pres-
ence of SEB. Five observations point to IFN-g release from the T 
cells and subsequent secondary MHC class II induction on keratino-
cytes as being responsible for this effect: 1) presence of> 25% HLA-
DR+ keratinocytes at day 3 in cultures ofT cells, SEB, and control 
keratinocytes; 2) demonstration of IFN.g in supernatants from T 
cells alone or T cells incubated with SEB; 3) inhibition of the T-cell 
stimulation by control keratinocytes in the presence of SEB by a 
monoclonal antibody to IFN-g; 4) a delayed time response o~ the 
T-cell stimulation by control keratinocytes compared to kerat1110-
cytes pretreated with IFN-g in the presence of SEB (Fig 2~; and 5) 
abrogation of the T -cell stimulatory effect of control kerat~nocytes 
by fixation, whereas the effect of IFN-g-pretreated kerat1110cytes 
were not affected by this treatment (Fig 3). . 
It is worthwhile to question whether MHC class II+ ke~atm~­
cytes' ability to present superantigens to T cells has any bIOlogiC 
relevance. Aberrant MHC class II expression was proposed to con-
stitute a down-regulatory pathway in the immun~ respons~, because 
aberrandy expressed MHC class II induced antigen-speCific unre-
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sponsiveness in T-cell clones [7 - 11]. Antigen-specific unr~spon­
siveness of T cells is induced when the T cells do not proliferate 
upon occupancy of the T-cell receptor J29]. In t.he experiments 
described in this paper, the T cells proliferated vIgorously when 
incubated with superantigen and aberrantly MHC .class 11+ kerati-
nocytes (Fig 1, column 6), hence T-cell unresponsIveness was not 
induced. Thus the data in this paper support the hypothesis that 
MHC class 11+ keratinocytes in the presence of superantigen en-
hances the immune response. This contrasts with the proposed 
down-regulatory effect of MHC class 11+ keratinocytes on the im-
mune response to nominal antigen. Instead of decreasing inflamma-
tion, aberrantly expressed MHC class II molecules on keratinocytes 
would increase inflammation when superantigens are present. 
Several inflammatory skin diseases are known to be aggravated by 
staphylococcal colonization of the skin, e.g., atopic dermatitis, con-
tact eczema, and hand eczema. Staphylococci isolated from the skin 
of atopic dermatitis patients have recently been shown to be capable 
of producing superantigens.· Staphyloccal superantigens may pene-
trate the injured skin barrier in these skin diseases, at least when the 
pruritic skin is scratched. MHC class 11+ keratinocytes, which are 
present in the upper layers of the epidermis, may then present su-
perantigen to traversing T cells. Cytokine release would in this case 
follow T -cell activation, leading to a further increase in inflamma-
tion. In particular, release of IFN-g from activated T cells would 
enhance MHC class II expression on keratinocytes, further increas-
ing the ability to present superantigen. This vicious circle would 
continue as long as superantigens are present. According to this 
theory removal of the staphylococci with antibiotics should abro-
gate superantigen presentation in the epidermis and decrease in-
flammation . Improvement of the inflammatory skin disease would 
follow the decreased inflammation. Thus the ability of MHC class 
11+ keratinocytes to present superantigen to T cells may explain why 
antibiotics demonstrate efficacy in the treatment of several inflam-
matory skin diseases colonized with staphylococci. 
Note Added in Proof During the review process Nickoloff et al 
published similar results in] ImmunoI150:2148-2159, 1993. 
This work was supported in part by grants from The Danish Medical Research 
Council 12-0837-1; The Dati ish Hospital FOlmdation for Medical Research, Re-
giOtl of Copell.hagel!, The Faroe Islatlds and Greenlatld 16/91; atld Tile Leo Re-
search Foundatiotl . We thank Cathy Yohe for editorial assistance. 
REFERENCES 
1. Mason OW, Barclay AN: Constitutive and inducible expression of Ia antigens. 
Imm,mobioI168:167 - 171,1984 
2. Sadegh-Nasseri S, Germain RN: A role for peptide in determining MHC class II 
structure. Nat ,m 353:167-170,1991 
3. Germain RN, Hendrix LR: MHC class II structure, occupancy and surface ex-
pression determined by post-endoplasmic reticulum antigen binding. Nature 
353:134 - 139, 1991 
4. Lampert lA, Suitters AJ, Chrisholm PM: Expression ofla antigen on epidertnal 
keratinocytes in graft-versus-host disease. Nat,m 293:149-150,1981 
5. Vole-Platzer B, Majdic 0, Knapp W, Wolff K, Hinterberger W, Lechner K, 
• McFadden J. Noble W, Camp R: Production of superantigenic exotox-
ins by staphylococcus au reus isolated from the skin of patients with atopic 
dermatitis (abstr). In: 8th International Congress ofImmunology, Abstracts. 
Springer Verlag, Budapest 1992, p 674. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Stingl G: Evidence ofHLA-DR antigen biosynthesis by human keratinocytes in 
disease.] ExpMed 159:1784-1789, 1984 
6. Basham TY, Nickoloff BJ, Merigan TC, Morhenn VB: Recombinant gamma 
interferon induces HLA-DR expression on cultured human keratinocytes. 
] Invest Dermatol 83:88 - 90, 1984 
7. Gaspari AA, Jenkins MK, Katz SI : Class II MHC-bearing keratinocytes induce 
antigen-specific unresponsiveness in hapten-specific THI clones.] Immunol 
141:2216-2220, 1988 
8. Markmann J, Lo 0, Naji A, Palmiter RD, Brinster RL, Heber-Katz E: Antigen 
presenting function of class II MHC expressing pancreatic beta cel ls. Nature 
336:476-479, 1988 
9. Quill H, Schwartz, RH: Stimulation of normal inducer T cell clones with antigen 
presented by purified Ia molecules in planar lipid membranes: specific induction 
of a long-lived state of proliferative nonresponsiveness. ] Immllnol138:3704_ 
3712,1987 
10. Jenkins MK, Schwartz RH: Antigen presentation by chemically modified spleno_ 
cytes induces antigen-specificTcell unresponsiveness in vitro and in vivo.] Exp 
Med 165:302-319, 1987 
11. Bal V, McIndoe A, Denton G, Hudson 0, Lombardi G, Lamb J, Lechler R: 
Antigen presentation by keratinocytes induces tolerance in human cells. Eur] 
ImmulloI20:1893-1897,1990 
12. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P: The VfJ-spe-
cific superantigen staphylococcal enterotoxin B : stimulation of mature T cells 
and clonal deletion in neonatal mice. Cell 56:27 - 35, 1989 
13. Choi Y, Kotzin B, Herron L, CallahanJ , Marrack P, Kappler J : Interaction of 
staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl 
Acad Sci USA 86:8941-8945, 1989 
14. Carlsson R, Fischer H, Sjogren HO: Binding of staphylococcal enterotoxin A to 
accessory cells is a requirement for its ability to activate human T -cells. 
] ImmunoI140:2484-2488, 1988 
15. Fleischer B, Schrezenmeier H : Tcell stimulation by staphylococcal enterotoxins. 
C lonally variable response and requirement for major bistocompatibility com_ 
plex class II molecules on accessory or target cells.] ExpMed 167:1697 -1707, 
1988 
16. Gasciogne NRJ, Ames KT: Direct binding of secreted T-cell receptor beta chain 
to superantigen associated with class II major histocompatibility complex pro_ 
tein. Proc Nat! Acad Sci USA 88:613-616, 1991 
17. MollickJA, Cook RG, Rich RR: Class II MHC molecules are specific receptors 
for staphylococcus enterotoxin A. Scieroce 244:817 -820,1989 
18. Tomai M, Kotb M, Majumdar G , Beachey EH: Superantigenicity of streptococcal 
M protein.] ExpMed 172:359-362,1990 
19. Boyce ST, Ham RG: Nortnal human epidermal keratinocytes. In: Weber MM, 
Seke!y L (cds.). III Vitro Models for Call'" Research. CRC Press, Boca Raton, FL, 
1983, pp 245-274 
20. Dustin ML, Singer KH, Tuck DT, Springer TA: Adhesion ofT lymphoblasts to 
epidermal keratinocytes is regulated by interferon gamma and is mediated by 
intercellular adhesion molecule I (ICAM-l).] Exp Med 167:1323 -1340,1988 
21 . Wesley CVV, Steinman RM, Hair LS, Luban J, Witmer MD, Koide S, Cohn ZA: 
Specific antimononuclear phagocyte monoclonal antibodies. Application to the 
production of dendritic cells and the tissue localization of macrophages.] EX]> 
Med 158:126-145,1983 
22. American Type Culture Collection. Cataloglle of Cell Lilies and Hybridomas. Rock_ 
ville, MD, ATCC, 1992 
23. Makonnen B,]untti N, Larsson A, Porath]: A one-step purification method for 
monoclonal antibodies based on salt-promoted adsorption chromatography on 
a 'thiofilic' adsorbent.] Imm,mol Met /, ads 102:173-182, 1987 
24. Bradford M: A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Anal Bio-
chern 72:248 - 254, 1976 
25. Fraser JD: High-affinity binding of staphylococcal enterotoxin A and B to HLA_ 
DR. Nature 339:221-223,1989 
26. SimonJC, Cruz PO, Bergstresser PR, Davis LS, Tigelaar RE: Phorbol myristate 
acetate-activated keratinocytes stimulate proliferation of resting periphetal 
blood mononuclear lymphocytes via a MHC-independent, but protein kinase 
C- and ICAM-I-dependent, mechanism.] Imm,moI146:476-484, 1991 
27. Matsui K, Boniface 11, Reay PA, Schild H, Groth BFDS, Davis M: Low affinity 
interaction of peptide-MHC complexes with T cell receptors. Science 
254:1788-1791,1991 
28. Noese! CV, Miedema F, Brouwer M, Ric MAD, Aarden LA, Lier RA WV: Regu_ 
latory properties of LFA-l ex and p chains in human T -lymphocyte activation . 
Nature 333:850 - 852, 1988 
29. DeSilva DR, Urdahl KB,Jenkins MK: C lonal anergy is induced in vitro by T cell 
receptor occupancy in the absence of proliferation.] Imm'H101147:3261-3267, 
1991 
